Evolus, Inc. (EOLS) shareholders
Close on Nov 17, 2026Market cap $441.88MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Timothy P. Lynch | 6,425,726 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Wilmot B. Harkey Joint filing with Nantahala Capital Management, LLC (8.85%), Daniel Mack (8.85%) | 5,726,857 | 8.85% | 13G (passive) amendment | Sep 30, 2025 |
| Soleus Capital Group, LLC Joint filing with Soleus Capital Master Fund, L.P. (7.70%), Soleus Capital, LLC (7.70%) and 3 more | 5,090,000 | 7.70% | 13G (passive) amendment | Sep 30, 2026 |
| Kevin Tang Joint filing with Tang Capital Management, LLC (7.90%), Tang Capital Partners, LP (5.50%) | 4,997,399 | 7.90% | 13G (passive) amendment | Mar 31, 2025 |
| BlackRock, Inc. | 4,364,896 | 6.90% | 13G (passive) amendment | Dec 31, 2024 |
| Perceptive Advisors LLC Joint filing with Joseph Edelman (6.40%), Perceptive Life Sciences Master Fund, Ltd. (6.40%) | 4,129,142 | 6.40% | 13G (passive) amendment | Mar 31, 2025 |
| Nantahala Capital Management, LLC Joint filing with Wilmot B. Harkey (5.90%), Daniel Mack (5.90%) | 3,751,343 | 5.90% | 13G (passive) | Mar 31, 2025 |
| Soleus Capital Management, L.P. Joint filing with Soleus Capital Master Fund, L.P. (5.30%), Soleus Capital, LLC (5.30%) and 3 more | 3,480,000 | 5.30% | 13G (passive) | Aug 27, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of EOLS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 11,204,042 | 16.96% | $77.76M | +4,827,185 | 1.29% |
| BlackRock, Inc. | 4,840,828 | 7.33% | $33.60M | +550,445 | 0.00% |
| Braidwell LP | 3,155,209 | 4.78% | $21.90M | +50,000 | 0.81% |
| Frazier Life Sciences Management, L.P. | 2,630,665 | 3.98% | $18.26M | – | 0.40% |
| Perceptive Advisors LLC | 2,459,285 | 3.72% | $17.07M | +1,172,423 | 0.26% |
| Vanguard Capital Management LLC | 2,362,893 | 3.58% | $16.40M | −107,515 | 0.00% |
| Assenagon Asset Management S.A. | 1,816,360 | 2.75% | $12.61M | +1,218,215 | 0.01% |
| Millennium Management LLC | 1,787,929 | 2.71% | $12.41M | +326,770 | 0.00% |
| State Street Corp | 1,697,294 | 2.57% | $11.78M | +376,504 | 0.00% |
| Geode Capital Management, LLC | 1,608,394 | 2.44% | $11.17M | +227,056 | 0.00% |
| Stonepine Capital Management, LLC | 1,590,162 | 2.41% | $11.04M | −168,929 | 6.23% |
| Point72 Asset Management, L.P. | 1,508,518 | 2.28% | $10.47M | New | 0.01% |
| Pinnacle Associates Ltd | 1,487,264 | 2.25% | $10.32M | +328,369 | 0.11% |
| Armistice Capital, LLC | 1,436,000 | 2.17% | $9.97M | +40,000 | 0.12% |
| Rice Hall James & Associates, LLC | 1,289,888 | 1.95% | $8.95M | +35,069 | 0.44% |
| AWH Capital, L.P. | 1,250,000 | 1.89% | $8.68M | +625,000 | 3.01% |
| Goldman Sachs Group Inc | 1,219,419 | 1.85% | $8.46M | +133,021 | 0.00% |
| Soleus Capital Management, L.P. | 822,428 | 1.25% | $5.71M | −1,422,932 | 0.20% |
| Soviero Asset Management, LP | 770,000 | 1.17% | $5.34M | +89,627 | 2.25% |
| UBS Group AG | 752,679 | 1.14% | $5.22M | −202 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 158 | 55M | 84.0% | 33 / 56 | 40 / 20 | 13M | 4M |
| Q1 2026 | 147 | 46M | 69.1% | 27 / 56 | 43 / 45 | 11M | 11M |
| Q4 2025 | 169 | 49M | 74.5% | 41 / 53 | 47 / 31 | 11M | 17M |
| Q3 2025 | 160 | 55M | 83.1% | 24 / 57 | 52 / 36 | 9M | 13M |
| Q2 2025 | 172 | 59M | 88.7% | 28 / 63 | 51 / 34 | 12M | 8M |
| Q1 2025 | 179 | 54M | 82.2% | 31 / 59 | 56 / 15 | 8M | 5M |
| Q4 2024 | 164 | 52M | 78.6% | 26 / 55 | 49 / 25 | 6M | 5M |
| Q3 2024 | 165 | 50M | 76.4% | 31 / 55 | 43 / 21 | 8M | 9M |
| Q2 2024 | 156 | 55M | 83.7% | 26 / 71 | 38 / 33 | 11M | 12M |
| Q1 2024 | 164 | 57M | 85.6% | 31 / 61 | 48 / 17 | 14M | 8M |
| Q4 2023 | 151 | 51M | 77.3% | 28 / 44 | 54 / 14 | 18M | 8M |
| Q3 2023 | 137 | 41M | 62.8% | 15 / 63 | 33 / 13 | 8M | 4M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
106 funds held EOLS in Q2 2026, 70% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of EOLS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,544,992 | 2.34% | $10.72M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,538,195 | 2.33% | $10.68M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 770,279 | 1.17% | $5.35M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 645,689 | 0.98% | $3.77M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 557,657 | 0.84% | $3.87M | 0.03% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 338,034 | 0.51% | $2.22M | 0.01% | May 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | 325,329 | 0.49% | $2.26M | 0.53% | Jun 30, 2026 |
| Schwab U.S. Small-Cap ETF | 309,043 | 0.47% | $2.03M | 0.01% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 287,795 | 0.44% | $1.89M | 0.01% | May 31, 2026 |
| iShares Micro-Cap ETF | 199,442 | 0.30% | $1.38M | 0.09% | Jun 30, 2026 |
| iShares U.S. Pharmaceuticals ETF | 171,630 | 0.26% | $1.19M | 0.10% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 144,427 | 0.22% | $843.45K | 0.01% | Jul 31, 2026 |
| Vanguard Health Care Index Fund | 143,338 | 0.22% | $940.30K | 0.00% | May 31, 2026 |
| Clearwater Select Equity Fund | 115,686 | 0.18% | $802.86K | 0.16% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 113,928 | 0.17% | $747.37K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David Moatazedi | See Remarks, Director | 499,592 | 0.76% | Sep 4, 2026 |
| Rui Avelar | See Remarks | 427,423 | 0.65% | Mar 20, 2026 |
| Tatjana Mitchell | Chief Financial Officer | 226,092 | 0.34% | Feb 19, 2026 |
| Tomoko Yamagishi-Dressler | Chief Marketing Officer | 89,949 | 0.14% | Aug 26, 2025 |
| Sandra Beaver | Chief Financial Officer | 167,089 | 0.25% | May 14, 2025 |
| Karah Herdman Parschauer | Director | 77,742 | 0.12% | Feb 19, 2026 |
| Brady Stewart | Director | 134,188 | 0.20% | Feb 19, 2026 |
| Albert G. White III | Director | 95,937 | 0.15% | Feb 19, 2026 |
| David N. Gill | Director | 86,887 | 0.13% | Feb 19, 2026 |
| Vikram Malik | Director | 321,109 | 0.49% | Feb 19, 2026 |
| Simone Blank | Director | 559,894 | 0.85% | Mar 11, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| David Moatazedi See Remarks, Director | Sep 2, 2026 | Sale | −105,108 | $9.04 | $950.18K | 499,592 |
| David Moatazedi See Remarks, Director | Mar 20, 2026 | Sale(10b5-1 plan) | −13,669 | $4.75 | $64.93K | 604,700 |
| Rui Avelar See Remarks | Mar 20, 2026 | Sale(10b5-1 plan) | −3,119 | $4.75 | $14.82K | 427,423 |
| Rui Avelar See Remarks | Mar 17, 2026 | Sale(10b5-1 plan) | −29,996 | $4.89 | $146.68K | 430,542 |
| David Moatazedi See Remarks, Director | Mar 17, 2026 | Sale(10b5-1 plan) | −116,720 | $4.89 | $570.76K | 618,369 |
| Rui Avelar See Remarks | Mar 16, 2026 | Option exercise | +8,804 | – | – | 460,538 |
| David Moatazedi See Remarks, Director | Mar 16, 2026 | Option exercise | +67,489 | – | – | 735,089 |
| Rui Avelar See Remarks | Feb 17, 2026 | Award | +94,913 | – | – | 451,734 |
| Albert G. White III Director | Feb 17, 2026 | Award | +45,559 | – | – | 95,937 |
| Brady Stewart Director | Feb 17, 2026 | Award | +45,559 | – | – | 134,188 |
| Tatjana Mitchell Chief Financial Officer | Feb 17, 2026 | Award | +121,489 | – | – | 226,092 |
| David Moatazedi See Remarks, Director | Feb 17, 2026 | Award | +313,212 | – | – | 667,600 |
| David N. Gill Director | Feb 17, 2026 | Award | +45,559 | – | – | 86,887 |
| Karah Herdman Parschauer Director | Feb 17, 2026 | Award | +45,559 | – | – | 77,742 |
| Vikram Malik Director | Feb 17, 2026 | Award | +45,559 | – | – | 321,109 |
| Rui Avelar See Remarks | Dec 22, 2025 | Sale(10b5-1 plan) | −2,261 | $7.15 | $16.17K | 356,821 |
| David Moatazedi See Remarks, Director | Dec 22, 2025 | Sale(10b5-1 plan) | −10,539 | $7.15 | $75.35K | 354,388 |
| Tatjana Mitchell Chief Financial Officer | Sep 8, 2025 | Award | +104,603 | – | – | 104,603 |
| Tomoko Yamagishi-Dressler Chief Marketing Officer | Aug 22, 2025 | Sale(10b5-1 plan) | −5,722 | $7.51 | $42.97K | 89,949 |
| Brady Stewart Director | Aug 15, 2025 | Buy | +30,000 | $6.82 | $204.60K | 88,629 |
| David Moatazedi See Remarks, Director | Jun 16, 2025 | Sale | −16,582 | $9.89 | $164.00K | 364,927 |
| David Moatazedi See Remarks, Director | Jun 13, 2025 | Sale | −111,323 | $10.05 | $1.12M | 381,509 |
| Albert G. White III Director | Jun 9, 2025 | Buy | +20,000 | $9.45 | $189.00K | 50,378 |
| Sandra Beaver Chief Financial Officer | May 13, 2025 | Sale(10b5-1 plan) | −6,494 | $10.02 | $65.07K | 167,089 |
| Rui Avelar See Remarks | May 12, 2025 | Sale(10b5-1 plan) | −3,385 | $9.87 | $33.41K | 359,082 |
| David Moatazedi See Remarks, Director | May 12, 2025 | Sale(10b5-1 plan) | −15,787 | $9.87 | $155.82K | 492,832 |
| David Moatazedi See Remarks, Director | Mar 27, 2025 | Sale(10b5-1 plan) | −6,251 | $12.40 | $77.51K | 508,619 |
| David Moatazedi See Remarks, Director | Mar 18, 2025 | Sale(10b5-1 plan) | −103,376 | $13.26 | $1.37M | 514,870 |
| Sandra Beaver Chief Financial Officer | Mar 18, 2025 | Sale(10b5-1 plan) | −8,996 | $13.26 | $119.29K | 173,583 |
| Tomoko Yamagishi-Dressler Chief Marketing Officer | Mar 18, 2025 | Sale(10b5-1 plan) | −4,536 | $13.26 | $60.15K | 95,671 |
| Rui Avelar See Remarks | Mar 18, 2025 | Sale(10b5-1 plan) | −27,904 | $13.26 | $370.01K | 362,467 |
| Karah Herdman Parschauer Director | Mar 12, 2025 | Sale | −12,888 | $12.99 | $167.42K | 32,183 |
| Brady Stewart Director | Mar 7, 2025 | Award | +7,364 | – | – | 58,629 |
| David Moatazedi See Remarks, Director | Mar 7, 2025 | Award | +95,399 | – | – | 618,246 |
| Rui Avelar See Remarks | Mar 7, 2025 | Award | +23,776 | – | – | 390,371 |
| Sandra Beaver Chief Financial Officer | Mar 7, 2025 | Award | +35,663 | – | – | 182,579 |
| Vikram Malik Director | Mar 7, 2025 | Award | +7,364 | – | – | 253,878 |
| Tomoko Yamagishi-Dressler Chief Marketing Officer | Mar 7, 2025 | Award | +17,832 | – | – | 100,207 |
| Simone Blank Director | Mar 7, 2025 | Award | +7,364 | – | – | 77,111 |
| Karah Herdman Parschauer Director | Mar 7, 2025 | Award | +7,364 | – | – | 45,071 |
| Albert G. White III Director | Mar 7, 2025 | Award | +7,364 | – | – | 30,378 |
| David N. Gill Director | Mar 7, 2025 | Award | +7,364 | – | – | 41,328 |
| Rui Avelar See Remarks | Dec 23, 2024 | Sale(10b5-1 plan) | −2,252 | $10.85 | $24.43K | 366,595 |
| David Moatazedi See Remarks, Director | Dec 23, 2024 | Sale(10b5-1 plan) | −10,502 | $10.85 | $113.95K | 522,847 |
| Sandra Beaver Chief Financial Officer | Dec 23, 2024 | Sale(10b5-1 plan) | −1,586 | $10.85 | $17.21K | 146,916 |
| Sandra Beaver Chief Financial Officer | Sep 6, 2024 | Sale | −3,276 | $14.98 | $49.07K | 148,502 |
| Tomoko Yamagishi-Dressler Chief Marketing Officer | Aug 30, 2024 | Sale | −5,631 | $15.85 | $89.25K | 82,375 |
| Albert G. White III Director | Jul 1, 2024 | Award | +23,014 | – | – | 23,014 |
| David Moatazedi See Remarks, Director | Jun 6, 2024 | Sale | −175,940 | $12.59 | $2.22M | 533,349 |
| David Moatazedi See Remarks, Director | Jun 6, 2024 | Option exercise | +175,940 | $7.28 | $1.28M | 709,289 |
| David Moatazedi See Remarks, Director | Jun 5, 2024 | Option exercise | +155,278 | $5.46 | $847.82K | 688,627 |
| David Moatazedi See Remarks, Director | Jun 5, 2024 | Sale | −155,278 | $12.92 | $2.01M | 533,349 |
| David Moatazedi See Remarks, Director | Jun 4, 2024 | Sale | −140,214 | $12.73 | $1.78M | 533,349 |
| Vikram Malik Director | Jun 3, 2024 | Sale | −7,500 | $12.96 | $97.20K | 246,514 |
| David N. Gill Director | May 14, 2024 | Sale | −6,718 | $12.60 | $84.65K | 33,964 |
| Vikram Malik Director | May 13, 2024 | Sale | −28,000 | $12.93 | $362.04K | 254,014 |
| David N. Gill Director | May 13, 2024 | Sale | −3,643 | $12.72 | $46.34K | 40,682 |
| Rui Avelar See Remarks | May 10, 2024 | Sale | −3,441 | $12.72 | $43.77K | 368,847 |
| David Moatazedi See Remarks, Director | May 10, 2024 | Sale | −16,051 | $12.72 | $204.17K | 673,563 |
| Sandra Beaver Chief Financial Officer | May 10, 2024 | Sale | −2,423 | $12.72 | $30.82K | 151,778 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Evolus's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,712 shares on Sep 17, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| David Moatazedi Officer, Director | Sep 2, 2026 | 105,108 | $950.02K | Sep 2, 2026 | Performance Shares |
| David Moatazedi Officer, Director | Jun 16, 2025 | 16,582 | $164.05K | Jun 16, 2025 | Performance Shares |
| David Moatazedi Officer, Director | Jun 13, 2025 | 111,323 | $1.12M | Jun 13, 2025 | Restricted Stock |
| Karah Herdman Parschauer Director | Mar 12, 2025 | 12,888 | $167.47K | Mar 12, 2025 | RESTRICTED STOCK |
| David Moatazedi Officer | Jun 6, 2024 | 200,000 | $2.54M | Jun 6, 2024 | STOCK OPTION EXERCISE |
| David Moatazedi Officer | Jun 5, 2024 | 155,278 | $1.97M | Jun 5, 2024 | STOCK OPTION EXERCISE |
| David Moatazedi Officer | Jun 4, 2024 | 140,214 | $1.78M | Jun 4, 2024 | RESTRICTED STOCK |
| Vikram Malik Officer | Jun 3, 2024 | 7,500 | $97.20K | Jun 3, 2024 | RETAIL PURCHASE |
| Vikram Malik Director | May 14, 2024 | 28,000 | $362.04K | May 13, 2024 | RETAIL SHARES |
| David N. Gill Director | May 13, 2024 | 10,361 | $131.58K | May 13, 2024 | RESTRICTED STOCK |
| Karah Herdman Parschauer Director | Jan 30, 2024 | 11,931 | $156.73K | Jan 30, 2024 | Restricted Stock |
| David Moatazedi Officer | Dec 6, 2023 | 82,648 | $826.48K | Dec 6, 2023 | RESTRICTED STOCK |
See a number that looks wrong?